Evidence map›Paper›PMID 36845114›Full record

ArticleFrontiers in immunology2023

Case report: The devil was hidden in the mastocytes - an unusually fulminant case of indolent systemic mastocytosis in a 45-year-old patient, missed for almost 20 years.

Aristeidis E Boukouris, Ioannis Michelakis, Dionysios Metaxas, Gianna Karapati, George Kanellis, Athina Lioni, Vasiliki Tzavara

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Aristeidis E Boukouris1st Department of Internal Medicine, Korgialenio-Benakio Red Cross General Hospital, Athens, Greece.
Ioannis Michelakis1st Department of Internal Medicine, Korgialenio-Benakio Red Cross General Hospital, Athens, Greece.
Dionysios Metaxas1st Department of Internal Medicine, Korgialenio-Benakio Red Cross General Hospital, Athens, Greece.
Gianna Karapati1st Department of Internal Medicine, Korgialenio-Benakio Red Cross General Hospital, Athens, Greece.
George KanellisHematopathology Department, Evangelismos Hospital, Athens, Greece.
Athina Lioni1st Department of Internal Medicine, Korgialenio-Benakio Red Cross General Hospital, Athens, Greece.
Vasiliki Tzavara1st Department of Internal Medicine, Korgialenio-Benakio Red Cross General Hospital, Athens, Greece.
Hellenic Red Cross · GREvangelismos Hospital · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Indolent systemic mastocytosis (ISM) represents the most common form of SM, typically following a slow clinical course. While anaphylactic reactions may come up in the life course of an ISM patient, these are often moderate and do not pose a threat to patient's health. Here, we present an undiagnosed case of ISM with recurrent severe anaphylactic episodes following consumption of food and emotional stress. One of these episodes led to anaphylactic shock, necessitating temporary mechanical ventilation and intensive care unit (ICU) support. Besides hypotension, a diffuse, itchy, red rash was the only notable clinical finding. Upon recovery, we found abnormally high baseline serum tryptase level as well as 10% bone marrow (BM) infiltration by multifocal, dense clusters of CD117

Indexed as

AnaphylaxisMastocytosis, SystemicBone MarrowHumansMast CellsMiddle AgedTryptasesTryptasescase reportcomafulminant presentationindolent systemic mastocytosissymptom mitigation

Identifiers

PMID36845114
PMCPMC9950552
OpenAlexW4319985253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.